Abstract
We previously developed a promoter-activated production (PAP) system using amplified ras oncogene to activate the cytomegalovirus (CMV) promoter controlling the foreign gene in mammalian cells. CHO cells were demonstrated to be suitable for the PAP system. Here, we show that very high-level production of a recombinant protein was achieved when the human CMV promoter was inserted into a glutamine synthetase (GS) minigene expression plasmid, pEE14. A highly productive host CHO cell line, ras clone I containing amplified ras oncogene, was further transfected with the plasmid expressing both hIL-6 gene and GS minigene, and selected with methionine sulphoximine. We were able to establish a hIL-6 hyper-producing cell line, D29, which exhibited a peak productivity rate of approximately 40 μg hIL-6 10−6 cells day−1 through a combination of the PAP system and the GS gene amplification system. The cellular productivity of D29 cells was about 13-fold higher than control hIL-6-producing cells derived from CHO cells whose hIL-6 gene was amplified by the GS gene amplification system, and about 5-fold higher than the I13 cells established by the PAP system, which contains amplified ras oncogene and non-amplified hIL-6 gene. When D29 cells were cultured for a month, an accumulation rate of approximately 80 μg hIL-6 ml−1 per 3 days was achieved on the 9th day. These results indicate that this PAP and GS hybrid system enables the efficient and rapid establishment of recombinant protein hyper-producing cell lines.
References
Chen C. and Okayama H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752.
Cockett M.I. Bebbington C.R. and Yarranton G.T. 1990. High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene ampli cation. Bio/Technology 8: 662-667.
Izumi M., Miyazawa H., Kamakura T., Yamaguchi I., Endo T. and Hanaoka F. 1991. Blasticidin S-resistance gene (bsr): A novel selectable marker for mammalian cells. Exp Cell Res 197: 229-233.
Katakura Y., Seto P., Miura T., Ohashi H., Teruya K. and Shirahata S. 1999. Productivity enhancement of recombinant protein in CHO cells via speci c promoter activation by oncogenes. Cytotechnology 31: 103-109.
Kemball-Cook G., Garner I., Imanaka Y., Nishimura T., O'Brien D.P., Tuddenham E.G. and McVey J.H. 1994. High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector. Gene 139: 275-279.
Kito M., Itami S., Fukano Y., Yamana K. and Shibui T. 2002. Construction of engineered CHO strains for high-level pro-duction of recombinant proteins. Appl Microbiol Biotechnol 60: 442-448.
Schimke R.T. 1988. Gene ampli cation in cultured cells. J Biol Chem 263: 5989-5992.
Shirahata S., Watanabe J., Teruya K., Yano T., Osada K., Ohashi H., Tachibana H., Kim E.H. and Murakami H. 1995. E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells. Biosci Biotechnol Biochem 59: 345-347.
Teruya K., Yano T., Shirahata S., Watanabe J., Osada K., Ohashi H., Tachibana H., Kim E.H. and Murakami H. 1995. Ras ampli cation in BHK-21 cells produces a host cell line for further rapid establishment of recombinant protein hyper-producing cell lines. Biosci Biotechnol Biochem 59: 341-344.
Teruya K., Zhang Y., Katakura Y. and Shirahata S. 2002. A regulatable selective system facilitates isolation of heterolo-gous protein hyper-producing mammalian cells without gene ampli cation. Cytotechnology 40: 13-22.
Yano T., Teruya K., Shirahata S., Watanabe J., Osada K., Tachibana H., Ohashi H., Kim E.H. and Murakami H. 1994. Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 16: 167-178. 17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dong, XY., Teruya, K., Katakura, Y. et al. A Hybrid System Using Both Promoter Activation and Gene Amplification for Establishing Exogenous Protein Hyper-Producing Cell Lines. Cytotechnology 43, 11–17 (2003). https://doi.org/10.1023/B:CYTO.0000039901.92984.7a
Published:
Issue Date:
DOI: https://doi.org/10.1023/B:CYTO.0000039901.92984.7a